These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 23888554)
1. Seroprevalence of HDV infection in HBsAg positive population in Ismailia, Egypt. Gomaa NI; Metwally LA; Nemr N; Younis S Egypt J Immunol; 2013; 20(1):23-8. PubMed ID: 23888554 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis D virus infection among hepatitis B virus surface antigen positive individuals in Upper Egypt: Prevalence and clinical features. Makhlouf NA; Morsy KH; Mahmoud AA J Infect Public Health; 2019; 12(3):350-356. PubMed ID: 30833193 [TBL] [Abstract][Full Text] [Related]
3. Seroepidemiology and clinical features of hepatitis delta among HBsAg carriers: a study from Hepatitis Clinic of Iranian Blood Transfusion Organization. Keshvari M; Alavian SM; Aghaee B; Behnava B; Mahdavi M; Fesharaki MG; Sharafi H Transfus Med; 2014 Dec; 24(6):411-7. PubMed ID: 25523297 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of hepatitis B and hepatitis D coinfection in asymptomatic blood donors in Iran. Attaran MS; Sharifi Z; Hosseini SM; Samei S; Ataee Z APMIS; 2014 Mar; 122(3):243-7. PubMed ID: 23879563 [TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan. Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646 [TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of hepatitis D virus and its risk factors in the west of Iran. Mohammad Alizadeh AH; Ranjbar M; Tehrani AS; Keramat F; Mamani M; Rezazadeh M; Aini P; Khalilian A; Majlesi A; Hajilooi M J Microbiol Immunol Infect; 2010 Dec; 43(6):519-23. PubMed ID: 21195980 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis delta in HIV-infected individuals in Europe. Soriano V; Grint D; d'Arminio Monforte A; Horban A; Leen C; Poveda E; Antunes F; de Wit S; Lundgren J; Rockstroh J; Peters L AIDS; 2011 Oct; 25(16):1987-92. PubMed ID: 21857493 [TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology of hepatitis D virus circulating in Southwestern Nigeria. Opaleye OO; Japhet OM; Adewumi OM; Omoruyi EC; Akanbi OA; Oluremi AS; Wang B; Tong Hv; Velavan TP; Bock CT Virol J; 2016 Apr; 13():61. PubMed ID: 27044424 [TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of serum HBsAg positivity and hepatitis delta virus infection among blood donors in Southeastern Turkey. Mese S; Nergiz S; Tekes S; Gul K Clin Ter; 2014; 165(2):95-8. PubMed ID: 24770811 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis d infection in patients with hepatitis B virus-related liver diseases in Accra, Ghana. Asmah RH; Boamah I; Afodzinu M; Brown CA; Brandful J; Adjei DN; Adiku T; Gyasi R; Wiredu EK West Afr J Med; 2014; 33(1):32-6. PubMed ID: 24872264 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea. Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950 [TBL] [Abstract][Full Text] [Related]
15. HDV seroprevalence in HBsAg positive patients. Abbasi A; Bhutto AR; Butt N; Mahmood K J Coll Physicians Surg Pak; 2014 Sep; 24(9):624-7. PubMed ID: 25233963 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis delta virus infection among hepatitis B virus surface antigen positive patients circulating in the largest province of Pakistan. Zaidi G; Idrees M; Malik FA; Amin I; Shahid M; Younas S; Hussain R; Awan Z; Tariq A; Parveen K Virol J; 2010 Oct; 7():283. PubMed ID: 20977704 [TBL] [Abstract][Full Text] [Related]
17. Delta virus and hepatitis B surface antigen in chronic liver diseases. Abdel-Fattah S; el-Kholy MS; Abdel-Fattah SM; el-Shimi S; el-Rasad MM; Mikhail TH; Wassef E J Egypt Public Health Assoc; 1991; 66(3-4):427-39. PubMed ID: 1791415 [TBL] [Abstract][Full Text] [Related]
18. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey. Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248 [TBL] [Abstract][Full Text] [Related]
19. Genotypes and phylogenetic characterization of hepatitis B and delta viruses in Egypt. Saudy N; Sugauchi F; Tanaka Y; Suzuki S; Aal AA; Zaid MA; Agha S; Mizokami M J Med Virol; 2003 Aug; 70(4):529-36. PubMed ID: 12794714 [TBL] [Abstract][Full Text] [Related]
20. The effect of HIV disease on serum markers of hepatitis delta infection in intravenous drug abusers. Lake-Bakaar G; Bhat K; Govindarajan S J Lab Clin Med; 1994 Oct; 124(4):564-8. PubMed ID: 7930880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]